Showing posts with label Longitude Capital. Show all posts
Showing posts with label Longitude Capital. Show all posts
Wednesday, October 10, 2012
Longitude Capital closes $385M life sciences fund
Private equity firm Longitude Capital closed a fund that will invest in the life sciences after raising $385 million for it. This fund, Longitude Venture Parnters II LP, will invest in drug development and medical technology. The firm had hoped to raise at least $325 million for it.
Monday, August 27, 2012
Fresh off Medicare win, CardioDx lines up $58 million financing round
CardioDx Inc. lined up $58 million in a two-tranche round – about $30 million now and the remainder later this year – as it expands following recently won Medicare coverage of its heart disease diagnostic test. Singapore-based investor Temasek joined a slew of existing CardioDx backers, including Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, TPG Biotech and GE Capital, in the financing, the Palo Alto company said Monday.
Subscribe to:
Posts (Atom)